Format

Send to

Choose Destination
Chem Commun (Camb). 2016 Aug 4;52(60):9327-42. doi: 10.1039/c6cc03439j. Epub 2016 Jun 24.

Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small molecules.

Author information

1
Department of Chemistry, Center for Drug Discovery, Purdue University, West Lafayette, IN 47907, USA. hsintim@purdue.edu.

Abstract

Bacteria utilize nucleotide-based second messengers to regulate a myriad of physiological processes. Cyclic dinucleotides have emerged as central regulators of bacterial physiology, controlling processes ranging from cell wall homeostasis to virulence production, and so far over thousands of manuscripts have provided biological insights into c-di-NMP signaling. The development of small molecule inhibitors of c-di-NMP signaling has significantly lagged behind. Recent developments in assays that allow for high-throughput screening of inhibitors suggest that the time is right for a concerted effort to identify inhibitors of these fascinating second messengers. Herein, we review c-di-NMP signaling and small molecules that have been developed to inhibit cyclic dinucleotide-related enzymes.

PMID:
27339003
DOI:
10.1039/c6cc03439j
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Royal Society of Chemistry
Loading ...
Support Center